Close X
Thursday, November 14, 2024
ADVT 
International

US announces additional H-2B visas for FY 2024

Darpan News Desk IANS, 20 Nov, 2023 12:51 PM
  • US announces additional H-2B visas for FY 2024

New York, Nov 20 (IANS) The US Departments of Labor and Homeland Security have announced an additional 64,716 H-2B temporary non-agricultural worker visas for FY 2024.

This allotment is in addition to the Congressionally-mandated 66,000 H-2B visas that are available each fiscal year, and permits employers to temporarily hire non-citizens to plug worker shortages in the US.

"By making these supplemental visas available at the outset of FY 2024, the Departments will help ensure US businesses with workforce needs are able to plan ahead and find the seasonal and temporary workers they need," the US Citizenship and Immigration Services (USCIS) announced this week.

The H-2B supplemental includes an allocation of 20,000 visas to workers from Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Haiti, and Honduras.

In addition to the 20,000 country-specific allocation, 44,716 supplemental visas are available to returning workers who received H-2B visas, or were otherwise granted H-2B status during one of the last three fiscal years.

The rule allocates these supplemental visas for returning workers between the first half and second half of the fiscal year to account for the need for additional seasonal and other temporary workers over the course of the year, with a portion of the second half allocation reserved to meet the demand for workers during the summer season.

The semiannual cap of 33,000 H-2B visas authorised under the Immigration and Nationality Act (statutory cap) for the first half of FY 2024 was reached on October 11, 2023.

These supplemental visas are available only to the US businesses that are suffering irreparable harm or will suffer impending irreparable harm without the ability to employ all the H-2B workers requested in their petition, as attested by the employer on a new attestation form.

MORE International ARTICLES

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided

With Trump sick, all eyes on Wednesday's VP debate

With Trump sick, all eyes on Wednesday's VP debate
Questions persist about Donald Trump's health following his COVID-19 diagnosis, as well as the age of 77-year-old challenger Joe Biden.

With Trump sick, all eyes on Wednesday's VP debate